FindTrial
Sign In

Management of cerebral palsy/motor disability in children

Evaluation of Kashyapokta Upanaha in the Management of spasticity in Children with Cerebral Palsy-A Randomized Controlled Clinical Trial - CP

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2021/02/031330
Enrollment
30
Registered
2021-02-16
Start date
Unknown
Completion date
Unknown
Last updated
2022-10-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: G00-G99- Diseases of the nervous system

Interventions

Intervention1: KASHYAPOKTA UPANAHA: THIS POULTICE FORMULATION IS MENTIONED IN KASHYAP SAMHITA IN SUTRA STHANA-SWEDADHYAYA.IT CONSISTS OF KINVA,ATASI,DADHI,KSHEERA,SAINDHAVA LAVAN,KANJI AND KUSHTHA.THI

Sponsors

SELF
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: CHILDREN WITH SPASTIC CEREBRAL PALSY FULFILLING THE DIAGNOSTIC CRITERIA

Exclusion criteria

Exclusion criteria: 1.CHILDREN WITH NON-SPASTIC CEREBRAL PALSY 2.AT THE TIME OF ENROLLMENT,IF THE CHILD IS FOUND TO BE NON-INCLUSIVE DUE TO UNDERLYING HEALTH CONDITION OR MEDICATION AND THUS NOT SUITABLE FOR UNDERGOING PROCEDURES WILL BE EXCLUDED. 3. CHILDREN WITH ANY KNOWN MAJOR CONGENITAL ANOMALIES LIKE CONGENITAL HEART DISEASE (CHD) ETC. WILL BE EXCLUDED

Design outcomes

Primary

MeasureTime frame
REDUCTION IN SPASTICITYTimepoint: 30 DAYS—

Secondary

MeasureTime frame
There is no effect of Kashyapokta Upanaha in reducing spasticity in children with Cerebral Palsy.Timepoint: 18 months—

Countries

India

Contacts

Public ContactDR PUJA C N PATHAK

SHRI B M K AYURVED MAHAVIDYALAYA,BELGAVI

azizarbar@gmail.com9844532113

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026